Heidelberg Pharma AG Shares Outstanding History (HPHA)
Heidelberg Pharma AG reported 46.8M shares outstanding at the end of fiscal 2025.
View full Heidelberg Pharma AG company overviewHeidelberg Pharma AG annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-11-30 | 46.8M | 180,000 | +0.39% |
| 2024 | 2024-11-30 | 46.6M | 0 | 0.00% |
| 2023 | 2023-11-30 | 46.6M | 20,000 | +0.04% |
| 2022 | 2022-11-30 | 46.6M | 12.4M | +36.28% |
| 2021 | 2021-11-30 | 34.2M | 6.0M | +21.16% |
| 2020 | 2020-11-30 | 28.2M | 0 | 0.00% |
| 2019 | 2019-11-30 | 28.2M | 80,000 | +0.28% |
| 2018 | 2018-11-30 | 28.1M | 5.7M | +25.30% |
| 2017 | 2017-11-30 | 22.4M | 9.5M | +73.63% |
| 2016 | 2016-11-30 | 12.9M | 3.6M | +38.88% |
| 2015 | 2015-11-30 | 9.3M | 1.5M | +19.05% |
| 2014 | 2014-11-30 | 7.8M | −23.5M | −75.00% |
| 2013 | 2013-11-30 | 31.3M | 0 | 0.00% |
| 2012 | 2012-11-30 | 31.3M | 9.7M | +44.75% |
| 2011 | 2011-11-30 | 21.6M | 3.2M | +17.38% |
| 2010 | 2010-11-30 | 18.4M | — | — |
Heidelberg Pharma AG quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-05-31 | 46.8M | 179,340 | +0.38% |
| Q1 2026 | 2026-02-28 | 46.8M | 179,340 | +0.38% |
| Q4 2025 | 2025-11-30 | 46.8M | — | — |
| Q2 2025 | 2025-05-31 | 46.6M | — | — |
| Q1 2025 | 2025-02-28 | 46.6M | — | — |
Heidelberg Pharma AG shares outstanding trends
Over the last five fiscal years, Heidelberg Pharma AG's shares outstanding moved from 28.2M to 46.8M, a change of 18.6M. The latest reported quarter, Q2 2026, shows 46.8M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
reported period-end shares
TickerStat displays period-end common shares from official filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Heidelberg Pharma AG source filings ↗